SecurityAMAR / Amarillo Biosciences, Inc. (02301P205)
IndustryPharmaceutical Preparations
President, CEO & ChairmanCHEN STEPHEN T
Institutional Owners1
Institutional Shares1,526 - 0.01%
Common Stock Shares Outstanding And Reserved28,731,754 shares (as of 2017-09-30)

Institutional Stock Ownership and Shareholders

Amarillo Biosciences, Inc. (OTC:AMAR) has 1 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,526 shares. Largest shareholders include Alpha Omega Wealth Management LLC.

Amarillo Biosciences, Inc. (OTC:AMAR) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

File DateFormInvestor Opt Prev Shares Current Shares Change
Prev Value (x$1000) Current Value (x$1000) Change
2018-02-06 13F-HR Alpha Omega Wealth Management LLC 1,526 1,526 0.00 0 0
CUSIP: 02301P205